Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

AI-powered stroke triage software meaningfully reduces treatment times, randomized trial finds

The investigation also used secure messaging, allowing clinicians to receive real-time alerts via their smartphones to notify them of a possible LVO minutes after the completion of a CT. 

artificial intelligence robot evaluates healthcare data

Novo Nordisk spends $60M on advanced AI in search of new cardiovascular medications

Novo Nordisk is working with Valo Health to identify potential new treatments for cardiometabolic conditions. If it proves to be a fruitful collaboration, the initial payment of $60 million will be just the beginning. 

Warfarin after TAVR is safe, but fails to boost outcomes

Researchers examined two-year data from transfemoral TAVR patients treated with low-dose aspirin and 30 days of warfarin or just aspirin on its own. 

Surgeons with University of Maryland Medical Center transplant a pig heart into a human patient

Surgeons make history again, transplant pig heart into human patient for second time ever

That same team that transplanted a pig heart into a human patient for the very first time in 2022 has now done it again. The patient is currently recovering from the procedure, which occurred on Sept. 20. 

cardiologists going through the certification process

Q&A: A closer look at the push in cardiology for a new, independent American Board of Cardiovascular Medicine

American College of Cardiology President B. Hadley Wilson, MD, discussed why the ACC and other leading cardiology groups are so eager to create a new, independent medical board. This has been a long-term goal for many years, he said, and now it may become a reality. 

Thumbnail

FDA approves empagliflozin for treating chronic kidney disease

The popular SGLT2 inhibitor, sold by Boehringer Ingelheim and Eli Lilly and Company under the name Jardiance, has already been approved by the FDA to treat type 2 diabetes and heart failure.

Vivek Reddy, MD, director of arrhythmia service and processor of medicine in cardiac electrophysiology, Mt. Sinai, New York, expolains the key takeaways from the ADVENT trial of pulsed field ablation at ESC 2023.

Pulsed field ablation shows potential to replace thermal ablation

Vivek Reddy, MD, explained that pulsed field ablation is associated with many benefits compared to the current standard of care in electrophysiology. 

artificial intelligence consultation

GPT-4 unlocks key insights from free-text radiology reports

Both ChatGPT and GPT-4 were found to be be good at analyzing free-text notes for lung cancer insights. One of the two programs, however, was able to outperform the other.